Clinical Trials Browser

Phase 1 × OTHER × eltrombopag × Clear all

Solid Tumor, Childhood

NCT04542382 2025-03-30

BCRPmarker

Phase 1 Completed

11 enrolled

Healthy Volunteers

NCT01550185 2022-07-22

Eltrombopag Olamine in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia

Phase 1 Terminated

10 enrolled

Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Basophilic, Acute, Leukemia, Eosinophilic, Acute, Leukemia, Myelomonocytic, Acute

NCT01491594 2014-04-02

Eltrombopag for the Prevention of Chemotherapy Induced Thrombocytopenia

Phase 1 Terminated

1 enrolled

Sarcoma

Bone Neoplasms, Sarcoma, Osteosarcoma, Neoplasms, Connective and Soft Tissue

Clinical Trials

CCPO011

BCRPmarker

Eltrombopag Olamine in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia

Eltrombopag for the Prevention of Chemotherapy Induced Thrombocytopenia